1. Home
  2. BFH vs XENE Comparison

BFH vs XENE Comparison

Compare BFH & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bread Financial Holdings Inc.

BFH

Bread Financial Holdings Inc.

HOLD

Current Price

$74.85

Market Cap

3.5B

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$44.05

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFH
XENE
Founded
1996
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.4B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BFH
XENE
Price
$74.85
$44.05
Analyst Decision
Hold
Strong Buy
Analyst Count
16
11
Target Price
$65.29
$53.91
AVG Volume (30 Days)
728.4K
757.1K
Earning Date
01-29-2026
11-03-2025
Dividend Yield
1.22%
N/A
EPS Growth
55.00
N/A
EPS
9.68
N/A
Revenue
$2,509,000,000.00
$7,500,000.00
Revenue This Year
$58.71
N/A
Revenue Next Year
$3.48
N/A
P/E Ratio
$7.76
N/A
Revenue Growth
1.70
N/A
52 Week Low
$38.21
$26.74
52 Week High
$78.98
$46.60

Technical Indicators

Market Signals
Indicator
BFH
XENE
Relative Strength Index (RSI) 60.85 52.85
Support Level $75.83 $42.44
Resistance Level $78.98 $46.25
Average True Range (ATR) 1.61 1.17
MACD -0.43 -0.08
Stochastic Oscillator 43.91 41.08

Price Performance

Historical Comparison
BFH
XENE

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: